Pharma Journalist -

Selexis SA and OSE Immunotherapeutics announced that they have signed a commercial license agreement that provides OSE Immunotherapeutics with access to high performance research cell…
Read More...

Pierre Fabre announced that they signed a definitive purchase agreement with Igenica Biotherapeutics to acquire several of Igenica assets. The agreement includes innovative…
Read More...

LSNE Contract Manufacturing announced that it has signed a manufacturing supply agreement with Selecta Biosciences to support the development of biologic therapies for rare and serious…
Read More...

Intellipharmaceutics International announced that its U.S. marketing partner, Par Pharmaceutical has launched the 10 and 20 mg strengths of its generic Focalin XR (dexmethylphenidate…
Read More...

Hebron Technology won a bid on the design and implementation of an oil-free compressed air pipe project at a pharmaceutical production facility owned by Tianjin Chase Sun…
Read More...

AstraZeneca announced that its Bydureon phase IIIb/IV EXSCEL (EXenatide Study of Cardiovascular Event Lowering) trial top-line results and met its primary safety objective of…
Read More...

GB Sciences announced that its subsidiary, Growblox Life Sciences has filed a patent application for the treatment of chronic pain and heart therapies based on myrcene-containing…
Read More...

DNAnexus announced that AstraZeneca  has selected its secure cloud-based platform for CGR (Centre for Genomics Research). Financial terms of the collaboration were not disclosed. The…
Read More...

Atox Bio announced that Reltecimod (previously AB103) successfully completed pre-specified futility analysis in patients with Necrotizing Soft Tissue Infections and will continue…
Read More...

Tom Privette has joined Acurian as vice president and head of global business development. He will be responsible to lead the commercial efforts of company sales organization worldwide.…
Read More...